Prexanil Combi

Quick links to important sections

Prexanil Combi

Medically reviewed

Laura Arias

Last updated on 22/12/2025

This page provides general, reference-level information compiled from official medical sources. It is not a substitute for professional medical advice, diagnosis, or treatment. For decisions about your health, please consult a qualified healthcare professional.

Overview of Prexanil Combi

Quick Facts: Prexanil Combi

Property Description
Active Ingredients Perindopril and Amlodipine
Form Oral tablet (Fixed-Dose Combination)
Pharmacological Classes ACE Inhibitor and Calcium Channel Blocker
Common Therapeutic Purpose Management of high blood pressure (Hypertension)
Origin Synthetic Compounds

What Type of Medicine is Prexanil Combi?

Prexanil Combi is a fixed-dose combination (FDC) medicine used for the effective management of high blood pressure (hypertension). Manufactured by Servier, it is a globally recognized brand name for this specific dual-ingredient therapy. It is categorized as a cardiovascular agent due to its action on the heart and blood vessels, designed to help reduce and maintain healthy blood pressure levels.

The FDC approach is clinically recognized for simplifying treatment for patients who require both drug classes, helping to increase consistency in therapy. The dual composition provides a comprehensive foundation for pressure management. This suggests the combination tablet is a highly effective way to reach and maintain your blood pressure goals.


What Are the Active Components of Prexanil Combi?

The medicine is composed of two distinct and synthetic active pharmaceutical ingredients (APIs): perindopril and amlodipine. Perindopril is classified as an Angiotensin-Converting Enzyme (ACE) inhibitor, while amlodipine is a calcium channel blocker.

Prexanil Combi is often used when a patient's blood pressure remains high despite using a single medication, offering a robust second-line approach. The inclusion of two distinct agents with complementary actions is a design feature intended to produce a stronger, more sustained effect on the circulatory system, promoting reliable, multi-pathway blood pressure regulation.


What Form Does Prexanil Combi Come In?

Prexanil Combi is manufactured exclusively as an oral tablet intended to be taken by mouth. The FDC format ensures that each dose contains a precise, unvarying amount of both the perindopril and amlodipine components.

This tablet form is intended as a substitution therapy for patients already stabilized on the individual components. This means the fixed-dose tablet offers an easy way to continue your established, effective treatment without managing multiple pills.

Regulatory References

  1. Dutch Regulatory Assessment for Perindopril/Amlodipine (Substitution Therapy)

What side effects are possible with Prexanil Combi?

Possible Side Effects and Safety Information

The safety profile for this fixed-dose combination of perindopril and amlodipine is based on adverse events documented in clinical studies and post-marketing surveillance, classified according to standard regulatory frequency tiers (e.g., Very Common, Common, Uncommon).

Frequency-Classified Adverse Reactions

Adverse reactions are grouped by how frequently they are reported and by the body system affected (System-Organ Class).

Classification Examples of Documented Effects SOC Categories Involved
Very Common Oedema (swelling, typically of the extremities) Vascular Disorders
Common Dizziness, headache, cough, low blood pressure (hypotension), and asthenia (weakness) Nervous System, Respiratory, Vascular, General
Uncommon Palpitations, mood changes, insomnia, vertigo, and syncope Cardiac, Nervous System, Psychiatric
Rare/Very Rare Angioedema, acute renal failure, hepatitis, myocardial infarction, and pancytopenia Immune System, Renal, Hepatobiliary, Blood

Serious Adverse Reactions and Safety Constraints

Serious adverse reactions documented in official labeling include Angioedema, a potentially life-threatening swelling of the face, limbs, or airways, which may occur at any time during treatment. Severe hypotension is also documented and may lead to secondary cardiovascular events.

The medicine is contraindicated for use in the second and third trimesters of pregnancy due to the risk of fetal toxicity. It is also not recommended for patients with a history of angioedema related to previous ACE inhibitor use or those with severe hepatic impairment. Certain effects, such as hypotension, are officially noted as more frequently observed at the beginning of treatment or following a change in dosage.

Overdose and Emergency Response

Overdose and When to Seek Help: Official Information

This information describes the documented risks and required actions in case of an overdose with Prexanil Combi, based on authoritative regulatory labeling.

Documented Overdose Manifestations

An overdose with this medication may lead to profound and prolonged systemic hypotension (very low blood pressure) due to excessive vasodilation. Official documents also note potential symptoms such as dizziness and fainting related to low blood pressure. More serious documented outcomes include the risk of circulatory shock and, in rare instances, acute renal failure or events like myocardial infarction secondary to severe hypotension.

Primary Clinical Features Potential Severe Outcomes
Prolonged Systemic Hypotension Circulatory Shock
Dizziness, Fainting Acute Renal Failure
Reflex Tachycardia Myocardial Infarction

Emergency Response and Seeking Urgent Care

Immediate medical attention is necessary if an overdose is suspected or occurs. The official regulatory instruction is for the patient to be placed immediately in a supine position (lying on their back). Management in a healthcare setting requires continuous cardiac and respiratory monitoring, along with frequent blood pressure checks. Treatment typically involves administering an intravenous infusion of physiological saline to restore blood volume and counteract the hypotensive effects. While there is no specific antidote, measures like activated charcoal may be considered early in treatment, and intravenous calcium gluconate may be used in managing the Amlodipine component.

Therapeutic Uses of Prexanil Combi

What Prexanil Combi Treats: Main Uses and Benefits

Therapeutic Support for Elevated Circulatory Pressure

The fixed-dose combination of perindopril and amlodipine is primarily used to help manage symptoms related to systemic imbalance in patients with Hypertension (high blood pressure). It is applied in conditions marked by persistently elevated circulatory pressure, where it supports the patient in addressing symptoms related to heightened physiological activity. The core therapeutic benefit is commonly used to help with addressing symptoms related to systemic imbalance and supporting long-term cardiovascular stability.

The medicine is indicated for the treatment of Essential Hypertension and is relevant for high-risk patients, including those with Stable Coronary Artery Disease. The combination is also relevant for patients in situations involving heightened systemic burden where additional management of discomfort is required, and may assist with easing challenging symptoms in these contexts. The fixed-dose format supports the patient during episodes of heightened physiological activity and may assist with maintaining functional stability.


Quick Fact: Therapeutic Support

Scenario Benefit Provided
Uncontrolled Hypertension Supports a more robust, multi-pathway therapeutic response.
High Cardiovascular Risk Contributes to easing the overall symptom load linked to circulatory stress.
Stable Coronary Artery Disease May assist with easing challenging symptoms in these specific contexts.

Eligibility and Restrictions for Use

Who can and cannot use Prexanil Combi?

The population eligibility for Perindopril/Amlodipine fixed-dose combination (e.g., Prexanil Combi) is strictly defined by regulatory documents, which establish absolute contraindications and conditional restrictions.


Contraindicated Populations (Must Not Use)

Condition / Status Regulatory Classification
History of angioedema (related to any ACE inhibitor) Contraindicated
Hypersensitivity to Perindopril, Amlodipine, or related drug classes Contraindicated
Second and Third Trimesters of Pregnancy Contraindicated (Fetal Toxicity Warning)
Severe Hypotension or Cardiogenic Shock Contraindicated
Concomitant use with Sacubitril/Valsartan or Aliskiren (in high-risk patients) Contraindicated

Populations with Restrictions

Population Group Regulatory Status
Children and Adolescents (< 18 years) Not Established/Not Recommended
Severe Renal Impairment (CrCL < 60 mL/min) Not Recommended/Avoid Use
Severe Hepatic Impairment Not Recommended
First Trimester of Pregnancy or Lactation Not Recommended
Geriatric Population (for initiation of treatment) Not Recommended

Eligibility is limited to adults stabilized on the individual components for the management of Essential Hypertension or Stable Coronary Artery Disease.

What should I know about interactions with other medicines?

Interactions with other medicines and products

This section details official drug interaction information for Prexanil Combi (Perindopril/Amlodipine) as classified by government regulatory authorities.


Formal Contraindications and Timing Rules

Co-administration with Sacubitril/Valsartan is strictly prohibited, requiring a 36-hour separation period due to the severe risk of Angioedema. Aliskiren is also contraindicated for patients diagnosed with Diabetes Mellitus or those with Impaired Renal Function (GFR below 60 mL/min).

Exposure-Altering and Pharmacodynamic Effects

The Amlodipine component is subject to CYP3A4 metabolic interactions. Co-administration with strong CYP3A4 Inhibitors (e.g., Ketoconazole) may lead to a clinically significant increase in Amlodipine exposure, while Inducers may decrease it. The combination carries a documented pharmacodynamic risk of Hyperkalemia (elevated serum potassium) when taken with Potassium-Sparing Diuretics (e.g., Spironolactone) or Potassium Supplements. Such combinations are generally not recommended.

Specific Substance Restrictions

Concomitant use with Lithium products may increase serum lithium concentrations due to reduced renal clearance. A dosage restriction is mandated for Simvastatin; its co-administered dose must not exceed 20 mg daily due to increased systemic exposure. Furthermore, the ingestion of Grapefruit Juice may slightly increase Amlodipine plasma concentrations, and Alcohol may potentiate the medicine’s hypotensive effects.

Mechanism of Action

Prexanil Combi is a fixed-dose combination product containing perindopril and amlodipine, which exert pharmacodynamic effects via two distinct molecular pathways.

Perindopril is a prodrug that is hydrolyzed in vivo to its active metabolite, perindoprilat. Perindoprilat acts as a competitive inhibitor of the angiotensin-converting enzyme (ACE) throughout systemic circulation and tissue beds. Inhibition of ACE blocks the conversion of angiotensin I to angiotensin II. This interruption of the renin-angiotensin-aldosterone system (RAAS) signaling decreases the concentration of the vasoconstrictor angiotensin II and reduces aldosterone secretion. Furthermore, perindoprilat reduces the enzymatic deactivation of bradykinin, a vasodilatory peptide.

Amlodipine is a dihydropyridine inhibitor of L-type voltage-dependent calcium channels. It binds to the alpha1 subunit of these channels, predominantly located on the vascular smooth muscle cell membrane. This interaction blocks the transmembrane influx of extracellular calcium ions. The resulting reduction in intracellular calcium concentration diminishes the activation of myosin light-chain kinase (MLCK), leading to reduced contractility of vascular smooth muscle. The dual mechanisms of action result in systemic physiological consequences of reduced total peripheral vascular resistance and increased vessel caliber, ultimately modulating systemic blood pressure.

Dosage and Administration Information

How to Use Prexanil Combi

Prexanil Combi is an oral, fixed-dose combination medicine administered as a single tablet once daily. The administration protocol requires the tablet to be swallowed, and it is recommended to take the dose preferably in the morning and before a meal (fasting state) to ensure consistent absorption.


Dosing and Administration Protocol

Administration Component Standard Guideline
Route Oral (Tablet)
Starting Dose 3.5 mg/2.5 mg once daily
Maximum Dose 14 mg/10 mg once daily
Dose Adjustment Interval Minimum of 7 to 14 days between dose changes

The dosing spectrum is defined by a standard starting dose of 3.5 mg/2.5 mg up to a maximum recommended daily dose of 14 mg/10 mg (Perindopril/Amlodipine). This gradual adjustment process is a key part of the usage protocol. If a dose is missed, the instruction is to skip the missed dose and continue with the next scheduled dose; doubling the dose is strictly prohibited.

Population Constraints

The fixed-dose product is not indicated for pediatric use, as safety and efficacy have not been established. Furthermore, the combination is generally not recommended for patients with severe renal impairment (creatinine clearance < 60 mL/min) or severe hepatic impairment, where individual component titration may be necessary.

Recent Clinical Evidence

Research evidence / Overview of Studies for Prexanil Combi


Evidence for Use in Essential Hypertension (High Blood Pressure)

Research on Prexanil Combi for high blood pressure primarily involves short- to intermediate-term Randomized Controlled Trials (RCTs). In these controlled settings, researchers examined how the medication relates to outcomes related to physiological strain, specifically focusing on measurements of systolic and diastolic blood pressure (BP). The studies included populations of adults who had essential hypertension.

Findings from these trials describe patterns observed related to changes in BP measurements over the treatment periods. Studies monitored the proportion of individuals observed to achieve pre-defined target ranges. Comparative research has also evaluated this fixed combination against each component taken separately or against a placebo. Short-term data is more common than long-term data, and follow-up durations were limited in the main comparative studies, providing less information on sustained outcomes over many years.


Evidence for Use in Stable Coronary Artery Disease

Research in stable coronary artery disease (CAD) explored whether the two components were associated with changes in major cardiovascular events. This research involves very large, long-term observational and controlled studies, tracking patients with conditions associated with vascular risk, such as a prior myocardial infarction or stroke. Outcomes monitored physiological strain or stress, focusing on documenting the incidence of major adverse cardiovascular events (MACE), including cardiovascular death.

Findings describe patterns observed regarding the incidence of these events over long follow-up periods. Evidence was also derived from settings with varying health complexities. A significant portion of the evidence is derived from subgroup analyses within larger outcome trials, which were not specifically designed to study the fixed-dose combination alone. Consequently, dedicated trials for this specific combination and long-term outcomes are limited.


What Is Still Unknown or Under Study

Long-term outcomes are not fully established with the same consistency as short-term measurements. Data for certain groups, such as those with very severe hypertension or specific organ dysfunction, remain insufficient. Comparative evidence is lacking for direct assessment against all other fixed-dose combination medications used for the same indications. Subgroup findings regarding individuals with complex health issues are still emerging, meaning subgroup findings are uncertain.

Key Studies & References The ADVANCE Trial (Action in Diabetes and Vascular Disease: Preterax and Diamicron MR Controlled Evaluation)

Frequently Asked Questions (FAQ)

Common questions about Prexanil Combi (FAQ)


Q: How quickly should I expect Prexanil Combi to start lowering my blood pressure?

Studies on this medication generally assess its full effect over a period of weeks. Official regulatory guidelines state that any change in dosage, if necessary, should not occur more frequently than every 7 to 14 days, reflecting the time needed for healthcare providers to evaluate the medication’s full blood pressure-lowering effect.


Q: What are the most commonly reported side effects people notice with Prexanil Combi?

According to official safety documentation, the most commonly reported side effects include oedema (swelling, typically of the ankles or hands), dizziness, headache, cough, low blood pressure (hypotension), and a feeling of weakness (asthenia).


Q: Is it normal to feel a bit dizzy when first starting Prexanil Combi?

Yes, dizziness is listed as a common side effect of the medicine. Official product information notes that effects like hypotension (low blood pressure) are observed more frequently when treatment is first started or after a dosage change.


Q: How long does the effect of one dose of Prexanil Combi last?

Prexanil Combi is prescribed as a once-daily tablet. This once-daily dosing is intended to provide sustained blood pressure control over a 24-hour period.


Q: Are there known long-term side effects from taking Prexanil Combi for many years?

The safety profile is built upon documented adverse events from clinical trials and post-marketing surveillance. While blood pressure lowering is established, regulatory information states that long-term safety data specifically for the fixed combination product are not established with the same consistency as short-term measurements.


Q: What kind of research supports the use of Prexanil Combi for blood pressure?

The use of this medication is supported by short- to intermediate-term randomized controlled trials (RCTs). These studies indicate that the combination is associated with achieving and maintaining systolic and diastolic blood pressure goals in adults who have essential hypertension.


Q: Are there any known severe but rare side effects of Prexanil Combi?

Yes. Serious adverse reactions are documented in the official safety labeling. These include Angioedema, which is a rare but potentially life-threatening swelling of the face, tongue, or throat, and Severe Hypotension (dangerously low blood pressure).


Q: Can I crush or split Prexanil Combi tablets?

The official protocol for administration requires the tablet to be swallowed whole. Regulatory labeling does not contain information authorizing the crushing or splitting of the tablet.


Q: What does the research say about the long-term cardiovascular benefits of Prexanil Combi?

Clinical research explores whether the two components are associated with outcomes related to major adverse cardiovascular events (MACE), such as cardiovascular death, heart attack, or stroke. Findings describe observed patterns regarding the incidence of these events, but dedicated trials for this specific combination are limited.


Q: Can Prexanil Combi cause weight gain or loss?

Official regulatory documents do not explicitly list weight gain or loss as a common side effect. However, the very common side effect of Oedema (swelling) is reported, which is associated with fluid retention and may be perceived as weight fluctuation.


Q: Are there any specific foods or drinks to avoid while on Prexanil Combi?

Yes. Regulatory information advises caution with the consumption of Grapefruit Juice, which may affect the concentration of the amlodipine component. Due to the perindopril component, intake of foods or supplements high in potassium may need careful consideration.


Q: Does Prexanil Combi interact with common pain relievers like ibuprofen?

Co-administration with non-steroidal anti-inflammatory drugs (NSAIDs), such as ibuprofen, may carry risks. Official information suggests this combination can increase the risk of certain adverse effects related to the perindopril component, such as worsening kidney function or hyperkalemia (high potassium).


Q: Does Prexanil Combi affect kidney function over time?

The perindopril component can affect kidney function in certain susceptible patients. Official safety guidance indicates that regular monitoring of creatinine and potassium levels in the blood is required, particularly for patients with existing risk factors. The medicine is not recommended for severe renal impairment.


Q: Can Prexanil Combi cause fatigue or tiredness?

Yes, fatigue is a possibility. Asthenia (weakness) is listed as a Common side effect in the regulatory documentation. Other common effects like dizziness and headache may also contribute to a feeling of general tiredness.


Q: Is Prexanil Combi safe for people with diabetes?

Clinical trials indicate the medicine can be used in diabetic populations. However, the medicine is strictly contraindicated for use alongside the drug aliskiren in patients who are also diagnosed with diabetes.


Q: Can Prexanil Combi interact with supplements like potassium or magnesium?

Yes, caution is advised with Potassium Supplements as the medicine carries a documented risk of hyperkalemia (high potassium). Core regulatory texts do not consistently document a specific interaction with magnesium supplements.


Q: Is there a generic version of Prexanil Combi available?

Generic versions of the fixed-dose combination (Perindopril Arginine / Amlodipine Besylate) have been approved in various regions. However, the availability of a specific generic formulation may vary by country.


Q: Will I need to take Prexanil Combi forever once I start it?

Prexanil Combi is used to manage and control high blood pressure, which is a chronic condition. It is typically intended for long-term treatment, as the medicine manages a chronic condition.


Q: Is Prexanil Combi suitable for younger adults with high blood pressure?

The safety and effectiveness of this medicine have not been established in children and adolescents. Its use is limited to adult patients who have been stabilized on the individual components for managing high blood pressure.


Q: Can taking Prexanil Combi affect my heart rate?

While the primary goal is blood pressure control, official safety information lists uncommon heart-related side effects. These include palpitations (an awareness of your heart beating) and syncope (fainting).


Q: Why do some people switch from a single pill to Prexanil Combi?

The combination tablet is commonly used as a substitution therapy for patients who are already well-controlled on the individual components. It is also indicated for patients whose high blood pressure is not adequately controlled when taking a single medication.


Q: Can Prexanil Combi cause changes in mood or sleep?

Yes, official safety information documents uncommon nervous system and psychiatric side effects. These include reports of mood changes and insomnia (difficulty sleeping).


Q: Does Prexanil Combi cause sensitivity to the sun?

Official regulatory documents do not commonly list increased photosensitivity as a frequent side effect. However, very rare skin reactions are documented, and these may sometimes be aggravated by sun exposure in sensitive individuals.


Q: How often do I need blood tests while on Prexanil Combi?

Official guidance notes that patients with certain risk factors, such as advanced age or underlying kidney impairment, may require frequent medical follow-up. This follow-up typically includes regular monitoring of potassium and creatinine levels in the blood.


Q: Are there any known interactions between Prexanil Combi and herbal supplements?

Caution is advised regarding supplements containing potassium, due to the documented risk of hyperkalemia. Furthermore, the amlodipine component is affected by certain metabolic pathways, and some herbal supplements may interfere with this process.


Q: Why might Prexanil Combi be less effective for some people?

The effectiveness of any blood pressure medication can vary between individuals. Regulatory documents acknowledge that data remains insufficient for certain specific populations, such as those with very severe hypertension or specific organ dysfunction, meaning the expected response in these groups is less certain.


Q: Is it okay to take Prexanil Combi at night instead of the morning?

Official instructions recommend taking the medicine once daily, preferably in the morning and before a meal (fasting state). The product information does not explicitly state the medical consequences or differences in effectiveness when the medicine is taken at night.


Q: Can people with liver issues use Prexanil Combi?

The medicine is Not Recommended for patients who have severe hepatic impairment (severe liver disease). Official information notes that due to a lack of established dosing regimens, caution is also advised regarding use in patients with mild to moderate liver issues.


Q: Is a persistent dry cough a possible side effect of Prexanil Combi?

Yes. A cough is listed as a Common side effect associated with the perindopril component (an ACE inhibitor). This cough is often described as non-productive, or dry, and typically stops when the medication is discontinued.

How should Prexanil Combi be stored and disposed of?

Storage and Disposal of Perindopril Arginine / Amlodipine Tablets

The following conditions define the official storage and disposal requirements for this medicine based on regulatory labeling.

Scope Element Official Regulatory Requirement
Storage Temperature Store at controlled room temperature, generally between 20 C and 25 C (68 F to 77 F) with limited excursions up to 30 C.
Protection & Handling Keep from freezing and protect from excessive moisture and direct light.
Container Rules Store the tablets in the original container and keep the container tightly closed.
Child Protection The medicine must be kept out of the sight and reach of children.

Disposal Requirements

Unused or expired medicine must be disposed of according to local regulations and should not be discarded in the household trash or flushed into wastewater systems. Patients should utilize community drug take-back programs where available for proper disposal.

Attention! Always consult to a doctor or pharmacist before using pills or medicines.

Available in countries:

Equivalent of Prexanil Combi found in:

A-Z Index: